Haleon (HLN) RNS Announcements

Add to Alert list
Date Time Source Announcement
02 Aug 2022 02:39 PM
RNS
Director/PDMR Shareholding
01 Aug 2022 01:39 PM
RNS
Total Voting Rights
29 Jul 2022 03:17 PM
RNS
Director/PDMR Shareholding
28 Jul 2022 06:15 PM
RNS
Director/PDMR Shareholding
28 Jul 2022 06:15 PM
RNS
Director/PDMR Shareholding
27 Jul 2022 07:00 AM
RNS
H1 Trading Update - Six Months Ended 30 June 2022
26 Jul 2022 06:00 PM
RNS
Director/PDMR Shareholding
26 Jul 2022 05:40 PM
RNS
Holding(s) in Company
26 Jul 2022 05:35 PM
RNS
Holding(s) in Company
22 Jul 2022 11:15 AM
RNS
Appointment of Joint Corporate Brokers
21 Jul 2022 05:30 PM
RNS
Director/PDMR Shareholding
21 Jul 2022 04:41 PM
RNS
Second Price Monitoring Extn
21 Jul 2022 04:36 PM
RNS
Price Monitoring Extension
20 Jul 2022 05:45 PM
RNS
Director/PDMR Shareholding
20 Jul 2022 05:45 PM
RNS
Director/PDMR Shareholding
20 Jul 2022 05:45 PM
RNS
Director/PDMR Shareholding
19 Jul 2022 11:30 AM
RNS
Holding(s) in Company
18 Jul 2022 06:01 PM
RNS
Holding(s) in Company
18 Jul 2022 06:00 PM
RNS
Holding(s) in Company
18 Jul 2022 04:41 PM
RNS
Second Price Monitoring Extn
18 Jul 2022 04:35 PM
RNS
Price Monitoring Extension
18 Jul 2022 12:55 PM
RNS
Total Voting Rights
18 Jul 2022 07:00 AM
RNS
Completion of Demerger and Admission of Shares

Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins.

Haleon share price launched at 317p in 2022 under the ticker HLN.

UK 100

Latest directors dealings